美国最高法院以 5 比 4 的投票结果否决了普渡制药破产计划中非经同意的第三方释放行为，判定萨克勒家族应对阿片类药物索赔承担责任。 US Supreme Court rules 5-4 against nonconsensual third-party releases in Purdue Pharma's bankruptcy plan, keeping Sackler family liable for opioid claims.
美国最高法院以 5 比 4 的表决结果裁定，破产法不允许非经同意的第三方释放，例如普渡制药破产计划中提出的那些。 The US Supreme Court has ruled in a 5-4 decision that nonconsensual third-party releases, such as those proposed in Purdue Pharma's bankruptcy plan, are not permissible under the Bankruptcy Code. 该决定推翻了一项原本可免除萨克勒家族对阿片类药物相关索赔责任的计划。 This decision overturns a plan that would have released the Sackler family from liability for opioid-related claims. 该裁决为影响针对第三方（包括保险公司和参与该计划的专业人士）的索赔的计划条款留下了不确定的法律前景。 The ruling leaves an uncertain legal landscape for plan provisions affecting claims against third parties, including insurers and professionals who work on the plan.